This multinational retrospective study compares the outcomes of patients with primary mediastinal large B-cell lymphoma (PMLBCL) with sclerosis after first-generation (dose-intensive regimens), third-generation (alternating regimens) and high-dose chemotherapy strategies, frequently with adjuvant radiation therapy.
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients / P. L. Zinzani, M. Martelli, M. Bertini, A. M. Gianni, L. Devizzi, M. Federico, G. Pangalis, J. Michels, E. Zucca, M. Cantonetti, S. Cortelazzo, A. Wotherspoon, A. J. M. Ferreri, F. Zaja, F. Lauria, A. De Renzo, M. A. Liberati, B. Falini, M. Balzarotti, A. Calderoni, A. Zaccaria, P. Gentilini, P. P. Fattori, E. Pavone, M. K. Angelopoulou, L. Alinari, M. Brugiatelli, N. Di Renzo, F. Bonifazi, S. A. Pileri, F. Cavalli. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 87:12(2002 Dec), pp. 1258-64-1264.
Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients
A. M. Gianni;
2002
Abstract
This multinational retrospective study compares the outcomes of patients with primary mediastinal large B-cell lymphoma (PMLBCL) with sclerosis after first-generation (dose-intensive regimens), third-generation (alternating regimens) and high-dose chemotherapy strategies, frequently with adjuvant radiation therapy.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.